Characteristic
Mutation homozygous class I or II (N) 41 (93.1)
Pancreatic insufficient (N) 43 (95.6)
Male (N) 20 (44.4)
Caucasian (N) 43 (95.6)
Hospital Admission prior to iPFT (N) 20 (44.4)
Age at iPFT testing in months (Mean, SD) 15.8 (3.16)
WFA z-score at time of iPFT (Mean, SD) -0.67 (0.93)
Height z-score at time of iPFT (Mean, SD) -0.4 (0.98)
WFL z-score at time of iPFT (Mean, SD) -0.01 (0.83)
Second hand smoke exposure (N) 15 (33.3)
Oral corticosteroid treatment in first year of life (N) 11 (24.4)
Oral antibiotics in first year of life (N) 41 (91.1)
Number oral antibiotics before iPFT (Median, range) 2 (0-10)
MSSA positive culture* (N) 30 (66.7)
MRSA positive culture* (N) 6 (13.3)
Pseudomonas aeruginosa positive culture* (N) 16 (35.6)
Stenotrophomonas maltophilia positive culture* (N) 8 (17.8)
WFA z-score at 6 months of age (Mean, SD) -0.72 (1.1)
WFL z-score at 6 months of age (Mean, SD) -0.51 (1.03)